Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro

Vascular Pharmacology

Volumn 47, Issue 1, 2007, Pages 18-24

  Xu, Hai Bin ^a   Huang, Zhao Quan ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cells; eNOS; Icariin; NF B; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVONOID; ICARIIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; QUERCETIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; EPIMEDII HERBA; HEART PROTECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIAL CELLS; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDES;

EID: 34249280557     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.03.002     Document Type: Article

References (35)

1. Bath P.M.W., Hassall D.G., Gladwin A.-M., Palmer R.M.J., and Martin J.F. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. 11 (1991) 254-260
2. Bell D.M., Johna T.E., and Loupz F.M. Endothelial dysfunction: implications for therapy of cardiovascular diseases. Ann. Pharmacother. 32 (1998) 459-470
3. Benito S., Lopez D., Saiz M.P., Buxaderas S., Sanchez J., Puig-Parellada P., and Mitjavila M.T. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br. J. Pharmacol. 135 (2002) 910-916
4. Chiesi M., and Schwaller R. Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. Biochem. Pharmacol. 49 (1995) 495-501
5. He W., Sun H., Yang B., Zhang D., and Kabelitz D. Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung 45 (1995) 910-913
6. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R.A.K., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Förstermann U., and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88 (2001) 14-22
7. Ji R.R., Li F.Y., and Zhang X.J. Effect of icariin on hypoxia induced vascular endothelial cells injury. Zhongguo Zhong Xi Yi Jie He Za Zhi 25 (2005) 525-530
8. Li H., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190 (2000) 244-254
9. Li H., Wallerath T., and Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7 (2002) 132-147
10. Li H., Wallerath T., Munzel T., and Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7 (2002) 149-164
11. Liu J., and Lou Y.J. Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin. J. Pharm. Biomed. Anal. 36 (2004) 365-370
12. Luscher T.F., and Barton M. Biology of the endothelium. Clin. Cardiol. 20 (1997) 3-10
13. Nong Z., Hoylaerts M., Van Pelt N., Collen D., and Janssens S. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ. Res. 81 (1997) 865-869
14. Oemas B.S., Tschudi M.R., and Godoy N. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97 (1998) 2494-2498
15. Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., Hirata K., Yasui H., Sakurai H., and Yoshida Y. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 110 (2002) 331-340
16. Ross R. The pathogenesis of a therosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
17. Synder S.H., and Bredt D.S. Biological roles of nitric oxide. Sci. Am. 266 (1992) 68-71
18. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., and Luscher T.F. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101 (2000) 1982-1989
19. Thomas W., Li H., Gödtel-Ambrust U., Schwarz P.M., and Forstermann U. A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12 (2005) 97-104
20. Tian L., Xin Z.C., Liu W.J., Yang Y.M., Liu G., Chen L., Fu J., and Wang L.L. Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic erectile dysfunction rat model. Zhonghua Yi Xue Za Zhi 84 (2004) 954-957
21. Tschudi M., Richard V., Buhler F.R., and Luscher T.F. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am. J. Physiol. 260 (1991) 13-20
22. Unger R.E., Krump-Konvalinkova V., Peters K., and Kirkpatrick C.J. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc. Res. 64 (2002) 384-397
23. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S., Karoui H., Tordo P., and Pritchard Jr. K.A. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9220-9225
24. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., and Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658
25. Wallerath T., Poleo D., Li H., and Forstermann U. Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J. Am. Coll. Cardiol. 41 (2003) 471-478
26. Wang Y.K., and Huang Z.Q. Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Pharmacol. Res. 52 (2005) 174-182
27. Wang Z.Q., and Lou Y.J. Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur. J. Pharmacol. 504 (2004) 147-153
28. Wang D., Gutkowska J., Marcinkiewicz M., Rachelska G., and Jankowski M. Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats. Cardiovasc. Res. 57 (2003) 186-194
29. Xia Y., Tsai A.L., Berka V., and Zweier J.L. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 273 (1998) 25804-25808
30. Xin Z.C., Kim E.K., Lin C.S., Liu W.J., Tian L., Yuan Y.M., and Fu J. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J. Androl. 5 (2003) 15-18
31. Yin X.X., Chen Z.Q., Dang G.T., Ma Q.J., and Liu Z.J. Effects of Epimedium pubescens icariine on proliferation and differentiation of human osteoblasts. Zhongguo Zhong Yao Za Zhi 30 (2005) 289-291
32. Zhang H.R., and Zhao T. Detection of antioxidative capacity of water soluble tablet vitamin. Sci. Instrum. Life 1 (2003) 40-41
33. Zhang Y.W., Morita I., Shao G., Yao X.S., and Murota S. Screening of Anti-hypoxia/reoxygenation agents by an in vitro model: Part 1. Natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells. Planta Med. 66 (2000) 114-118
34. Zhu D.Y., and Lou Y.J. Icariin-mediated expression of cardiac genes and modulation of nitric oxide signaling pathway during differentiation of mouse embryonic stem cells into cardiomyocytes in vitro. Acta Pharmacol. Sin. 27 (2006) 311-320
35. Zhu D.Y., Qu L.H., Zhang X.N., and Lou Y.J. Icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells. Eur. J. Pharmacol. 514 (2005) 99-110